Merck files for Medco spin off

Merck, the US-listed pharmaceuticals company, has filed with the Securities and Exchange Commission, to spin off a subsidiary it failed to float.

Merck is spinning off 100% of its subsidiary, Medco Health Solutions, to shareholders after abortive attempts to publicly offer the unit. Merck filed the initial public offering of Medco in April last year, aiming to sell a 20% stake and raise up to $1bn (€853m) in a deal led by Goldman Sachs and JP Morgan.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump